Tape strips detect molecular alterations and cutaneous biomarkers in skin of patients with hidradenitis suppurativa

J Am Acad Dermatol. 2024 Apr;90(4):749-758. doi: 10.1016/j.jaad.2023.11.048. Epub 2023 Dec 3.

Abstract

Background: Hidradenitis suppurativa (HS) has a high unmet need for better treatments. Biopsies are considered the gold standard for studying molecular alterations in skin. A reproducible, minimally invasive approach is needed for longitudinal monitoring in trials and in pediatric populations.

Objective: To determine whether skin tape strips can detect molecular alterations in HS and identify biomarkers of disease activity.

Methods: We performed RNA sequencing on tape strips collected from lesional and healthy-appearing (nonlesional) HS skin (n = 22) and healthy controls (n = 21). We correlated the expression of skin biomarkers between tape strips and a previously published gene-signature of HS biopsies.

Results: Tape strips detected upregulation of known HS biomarkers (eg, Interleukin[IL]-17A) in nonlesional and/or lesional skin and also identified novel clinically actionable targets, including OX40 and JAK3. The expression of Th17 and tumor necrosis factor-α pathways were highly correlated between tape strips and biopsies. HS clinical severity was significantly associated with expression of biomarkers (eg tumor necrosis factor-α , IL-17 A/F, OX40, JAK1-3, IL-4R) in HS lesional and/or nonlesional skin.

Limitations: Sample size. Tape stripping is limited in depth.

Conclusion: This study validates tape strips as a minimally-invasive approach to identify cutaneous biomarkers in HS. This provides a novel avenue for monitoring treatment efficacy and a potential step toward individualized therapy in HS.

Keywords: IL-17; RNA-sequencing; TNF; biomarkers; hidradenitis suppurativa; inflammation; tape strips; transcriptome.

MeSH terms

  • Biomarkers / metabolism
  • Child
  • Hidradenitis Suppurativa* / diagnosis
  • Hidradenitis Suppurativa* / drug therapy
  • Hidradenitis Suppurativa* / genetics
  • Humans
  • Skin / pathology
  • Tumor Necrosis Factor-alpha / therapeutic use
  • Up-Regulation

Substances

  • Tumor Necrosis Factor-alpha
  • Biomarkers